Change in serum proteome during allogeneic hematopoietic stem cell transplantation and clinical significance of serum C-reactive protein and haptoglobin.
10.3858/emm.2010.42.9.065
- Author:
Joohyun RYU
1
;
Se Ryeon LEE
;
Sung Goo PARK
;
Sunghyun KANG
;
Hyeoung Joon KIM
;
Byoung Chul PARK
Author Information
1. Medical Proteomics Research Center, KRIBB, Daejeon 305-333, Korea. parkbc@kribb.re.kr
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
biological markers;
C-reactive protein;
haptoglobin;
hematopoietic stem cell transplantation;
proteomics;
recurrence
- MeSH:
Adolescent;
Adult;
Biological Markers;
C-Reactive Protein/*metabolism;
Female;
Haptoglobins/*metabolism;
Hematopoietic Stem Cell Transplantation/*adverse effects;
Humans;
Male;
Middle Aged;
Proteome/*metabolism;
Proteomics;
Transplantation Conditioning;
Transplantation, Homologous;
Young Adult
- From:Experimental & Molecular Medicine
2010;42(9):651-661
- CountryRepublic of Korea
- Language:English
-
Abstract:
Successful hematopoietic stem cell transplantation (HSCT) involves the restoration of hematopoietic function after engraftment, arising from the differentiation and proliferation of hematopoietic stem cells. Several factors could influence the course of allogeneic-HSCT (allo-HSCT). Therefore, knowledge of serum proteome changes during the allo-HSCT period might increase the efficacy of diagnosis and disease prevention efforts. This study conducted proteomic analyses to find proteins that were significantly altered in response to allo-HSCT. Sera from five representative patients who underwent allo-HSCT were analyzed by 2-dimensional gel electrophoresis and liquid chromatography tandem mass spectrometry, and were measured on a weekly basis before and after allo-HSCT in additional 78 patients. Fourteen protein spots showing changes in expression were further examined, and most proteins were identified as acute phase proteins (APPs). Studies of 78 additional patients confirmed that C-reactive protein (CRP) and haptoglobin undergo expression changes during allo-HSCT and thus may have the potential to serve as representative markers of clinical events after allo-HSCT. Maximal CRP level affected the development of major transplant-related complications (MTCs) and other problems such as fever of unknown origin. Particularly, an increase in CRP level 21 days after allo-HSCT was found to be an independent risk factor for MTC. Maximal haptoglobin and haptoglobin level 14 days after allo-HSCT were predictive of relapses in underlying hematologic disease. Our results indicated that CRP and haptoglobin were significantly expressed during allo-HSCT, and suggest that their level can be monitored after allo-HSCT to assess the risks of early transplant-related complications and relapse.
